Human Biology

Published by: Wayne State University Press

translator disclaimer


Human Biology 79(6):637-647. 2007
doi: http://dx.doi.org/10.1353/hub.2008.0010

Effect of Apolipoprotein E Genotype and Saturated Fat Intake on Plasma Lipids and Myocardial Infarction in the Central Valley of Costa Rica
No Access

Yadong Yang1,2, Edward Ruiz-Narvaez1, Peter Kraft3, and Hannia Campos1,4

1Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115.

2Program for Population Genetics, Department of Environmental Health, Harvard School of Public Health, Boston, MA.

3Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Boston, MA.

4Centro Centroamericano de Población, Universidad de Costa Rica, San Pedro, Costa Rica.

ABSTRACT

We assessed the effect of APOE polymorphisms –491 A/T, C112R (APOE*4), and R158C (APOE*2) and saturated fat intake on plasma lipid levels and risk of myocardial infarction (MI) in 1,927 case subjects and 1,927 population-based control subjects matched for age, sex, and residence, all living in the Central Valley of Costa Rica. A significant gene-diet interaction (p = 0.0157) was observed. High saturated fat intake was associated with a 49% increased risk of MI (OR = 1.49; 95% CI, 1.16–1.92) among wild-type subjects. In contrast, high saturated fat intake was associated with a 2.2-fold increased risk of MI among carriers of APOE*2 (OR = 3.17; 95% CI, 1.58–6.36) and with a 1.6-fold increase among carriers of the –491T and APOE*4 variants together (OR = 2.59; 95% CI, 1.38–4.87). Consistently, a high fat diet elicited a greater response in LDL cholesterol among carriers of APOE*2 (+17%) and APOE*4 (+14%) compared to noncarriers (+6%). The frequency of APOE variants was similar in case and control subjects, although APOE*4 homozygotes were at increased risk of MI compared to noncarriers (OR = 2.26; 95% CI, 1.03–4.98). This study supports the hypothesis that the APOE*2 and APOE*4 variants increase susceptibility to MI in the presence of high saturated fat and could explain inconsistent findings on the effects of these variants on MI in various populations.

Received: July 25, 2005; Accepted: January 23, 2007

;

Published: 12 2007


Literature Cited

Artiga, M. J., M. J. Bullido, I. Sastre, et al. 1998. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 421:2105108. CrossRef, PubMed
Ballantyne, C. M., J. A. Herd, E. A. Stein, et al. 2000. Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy. J. Am. Coll. Cardiol 36:515721578. CrossRef, PubMed
Dallongeville, J., S. Lussier-Cacan, and J. Davignon. 1992. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis. J. Lipid Res 33:4447454. PubMed
Davignon, J., J. S. Cohn, L. Mabile, et al. 1999. Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clin. Chim. Acta 286:1–2115143. CrossRef, PubMed
Eichner, J. E., S. T. Dunn, G. Perveen, et al. 2002. Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am. J. Epidemiol 155:6487495. CrossRef, PubMed
Ewbank, D. C. 2002. Mortality differences by APOE genotype estimated from demographic synthesis. Genet. Epidemiol 22:2146155. CrossRef, PubMed
Lambert, J. C., T. Brousseau, V. Defosse, et al. 2000. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations—The ECTIM study. Hum. Mol. Genet 9:15761. CrossRef, PubMed
Laws, S. M., E. Hone, K. Taddei, et al. 2002. Variation at the APOE –491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol. Psychiatr 7:8886890. CrossRef, PubMed
Laws, S. M., E. Hone, S. Gandy, et al. 2003. Expanding the association between the APOE gene and the risk of Alzheimer's disease: Possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem 84:612151236. CrossRef, PubMed
Mahley, R. W. and S. C. Rall Jr.. 2000. Apolipoprotein E: Far more than a lipid transport protein. Annu. Rev. Genom. Hum. Genet 1:507537. CrossRef, PubMed
Melendez, C. 1982. Conquistadores y pobladores: Origenes historicossociales de los costarricenses. San José, Costa Rica Editorial Universidad Estatal a Distancia.
Molina-Jiménez, I. 1991. Costa Rica 1800–1850: El legado colonial y la génesis del capitalismo. San José, Costa Rica Editorial de la Universidad de Costa Rica.
Morera, B., R. Barrantes, and R. Marin-Rojas. 2003. Gene admixture in the Costa Rican population. Ann. Hum. Genet 67:pt. 17180. CrossRef, PubMed
Oikawa, S., A. Matsunaga, T. Saito, et al. 1997. Apolipoprotein E Sendai (arginine 145 <arrow-R> pro-line): A new variant associated with lipoprotein glomerulopathy. J. Am. Soc. Nephrol 8:5820823. PubMed
Ordovas, J. M. and V. Mooser. 2002. The APOE locus and the pharmacogenetics of lipid response. Curr. Opin. Lipidol 13:2113117. CrossRef, PubMed
Roks, G., M. Cruts, J. J. Houwing-Duistermaat, et al. 2002. Effect of the APOE –491 A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study. Am. J. Med. Genet 114:5570573. CrossRef, PubMed
Song, Y., M. J. Stampfer, and S. Liu. 2004. Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med 141:2137147. CrossRef, PubMed
Tinoco, L. D. 1977. Población de Costa Rica y orígines de los costarricenses. San José, Costa Rica Editorial Costa Rica.
Tunstall-Pedoe, H., K. Kuulasmaa, P. Amouyel, et al. 1994. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:1583612. CrossRef, PubMed
Viitanen, L., J. Pihlajamaki, R. Miettinen, et al. 2001. Apolipoprotein E gene promoter (–219 G/T) polymorphism is associated with premature coronary heart disease. J. Mol. Med 79:12732737. CrossRef, PubMed
Wilson, P. W., E. J. Schaefer, M. G. Larson, et al. 1996. Apolipoprotein E alleles and risk of coronary disease: A meta-analysis. Arterioscler. Thromb. Vasc. Biol 16:1012501255. CrossRef, PubMed

Article Tools

click this button to open

Citing Articles

 
BioOne is the product of innovative collaboration between scientific societies, libraries, academe and the private sector.
 
21 Dupont Circle NW, Suite 800, Washington, DC 20036 • Phone 202.296.1605 • Fax 202.872.0884
 
Copyright © 2016 BioOne All rights reserved